Literature DB >> 26449259

Recurrence and complications of pterygium extended removal followed by extended conjunctival transplant for primary pterygia.

Waleed A Allam1.   

Abstract

PURPOSE: To study the recurrence rate and complications after primary pterygium removal using pterygium extended removal followed by extended conjunctival transplant.
METHODS: Sixty-eight eyes of 57 consecutive patients with primary pterygia underwent pterygium removal using pterygium extended removal followed by extended conjunctival transplant between April 2010 and October 2014. The follow-up period lasted for at least 36 months after the procedure.
RESULTS: No recurrences were reported after a mean follow-up period of 40.0 ± 5.7 months (minimum of 36 months). One case (1.4%) developed Tenon granuloma at the donor site 2 weeks after surgery, and it was surgically removed. Transient graft swelling was observed in 22% of the cases, and transient diplopia was observed in 17.6%. Both graft swelling and diplopia resolved gradually in all cases during the early postoperative period. Loss of corrected distance visual acuity was not reported.
CONCLUSIONS: Pterygium extended removal followed by extended conjunctival transplant is an effective technique for primary pterygia and resulted in a 0% recurrence rate with minimal intraoperative and postoperative complications.

Entities:  

Mesh:

Year:  2015        PMID: 26449259     DOI: 10.5301/ejo.5000685

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  2 in total

1.  Safety and efficacy of pterygium extended removal followed by extended conjunctival transplant for recurrent pterygia.

Authors:  Waleed A Allam; Ahmed Roshdy Alagorie; Mohammed H Nasef; Molham A El-Bakary
Journal:  Int Ophthalmol       Date:  2022-01-03       Impact factor: 2.029

2.  Recurrence of Pterygium after Pterygium Excision with Stem Cell Graft and Amniotic Membrane Graft: A Comparison.

Authors:  Syed Ahmer Hussain; Kamran Haider Shaheen; Muhammad Saad Ullah; Aamir Furqan
Journal:  Cureus       Date:  2020-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.